-- 强生公司（JNJ）周三宣布，最新3期临床试验数据显示，Imaavy 能够为全身型重症肌无力患者提供超过两年的持续疾病控制。 该公司表示，这项3期临床试验及其开放标签扩展研究显示，在120周内，患者的症状和生活质量持续改善，致病抗体水平也显著降低，许多患者达到并维持了最低症状水平。 强生公司还宣布，其EPIC研究（首个Imaavy与另一种FcRn阻滞剂在全身型重症肌无力治疗中的头对头比较研究）目前正在招募受试者。
Price: $226.58, Change: $+0.42, Percent Change: +0.19%
FINEOS (ASX:FCL) reported first-quarter customer cash receipts of 56.5 million euros, up 9.3% year-on-year, driven by subscription fee revenues invoiced in January, according to a Monday Australian bourse filing.The company recorded customer cash receipts of 51.7 million euros for the three months ending March 31, 2025, an earlier filing showed.Exchange rate movements during the quarter had a positive impact of 1 million euros on the cash balance.The company's full-year revenue guidance remains in the range of 147 million euros to 152 million euros.The company's shares fell 1% in recent Monday trade.
Changyu Holding (SHA:603407) priced its initial public offering on the Shanghai Stock Exchange of 41 million shares at 13.86 yuan apiece to raise 568.3 million yuan, according to a weekend filing on the bourse.Proceeds will be invested in the company's zirconium oxychloride and deep-processing project, a nylon elastomer products project, and a bioceramics and functional ceramics products project.
Shaanxi Coal Industry's (SHA:601225) net profit attributable to shareholders in 2025 dropped 25% year on year to 16.8 billion yuan, or 1.73 yuan per share, according to a Saturday filing on the Shanghai bourse.The coal miner's share dropped 4% during the morning trade.The attributable profit a year earlier was 22.4 billion yuan, or 2.31 yuan per share.Operating revenue fell 14% to 158.2 billion yuan from 184.1 billion yuan in the previous year.